CHARGE THERAPEUTICS
Live / Allowed — Notice of allowance issued (as of 20 Jan 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 22 Apr 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99148525
- Mark type
- Stylized text
- Filed
- 22 Apr 2025
- Published for opposition
- 25 Nov 2025
- Attorney of record
- Tricia L. Schulz
Goods and services
- Class 005 — Pharmaceuticals: Biopharmaceutical preparations for the treatment of mitochondrial, cardiovascular, renal, ophthalmic, neurologic and metabolic diseases and disorders; Pharmaceutical preparations for the prevention of mitochondrial, cardiovascular, renal, ophthalmic, neurologic and metabolic diseases and disorders; Biological preparations for the treatment of cellular abnormalities
- Class 042 — Scientific and technological services: Scientific research and development; biopharmaceutical research, development and testing; Medical and scientific research in the field of mitochondrial, cardiovascular, renal, ophthalmic, neurologic, myopathic and metabolic systems
Owner
- STEALTH BIOTHERAPEUTICS INC., Needham, MA, US
- STEALTH BIOTHERAPEUTICS INC., Needham, MA, US
Prosecution history
- 20 Jan 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 Nov 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Nov 2025 — PUBLISHED FOR OPPOSITION
- 19 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 23 Oct 2025 — EXAMINER'S AMENDMENT ENTERED
- 23 Oct 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 23 Oct 2025 — EXAMINERS AMENDMENT E-MAILED
- 23 Oct 2025 — EXAMINERS AMENDMENT -WRITTEN
- 22 Sept 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 22 Sept 2025 — NON-FINAL ACTION E-MAILED
- 22 Sept 2025 — NON-FINAL ACTION WRITTEN
- 15 Sept 2025 — ASSIGNED TO EXAMINER
- 28 Aug 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 22 Apr 2025 — APPLICATION FILING RECEIPT MAILED